Vibativ
Payments companies reported to CMS as associated with Vibativ. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vibativ, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vibativ
These are the largest totals companies reported as associated with Vibativ. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gordon Bernard | Nashville, TN | Critical Care Medicine (Internal Medicine) | $306,750.00 |
| Todd Rice | Nashville, TN | Critical Care Medicine (Internal Medicine) | $106,618.90 |
| Vatsala Sastry | Brooksville, FL | Infectious Disease | $78,588.37 |
| Mohamed Erritouni | Delray Beach, FL | Infectious Disease | $30,051.42 |
| Alan Bulbin | Greenvale, NY | Infectious Disease | $20,358.85 |
| Nikhil Bhayani | Bedford, TX | Infectious Disease | $20,342.88 |
| Dino Delaportas | Bridgeport, WV | Infectious Disease | $16,131.65 |
| Micah Jacobs | Pittsburgh, PA | Infectious Disease | $16,078.76 |
| Vipul Desai | The Woodlands, TX | Infectious Disease | $15,329.50 |
| Brian Metzger | Austin, TX | Infectious Disease | $13,147.54 |
Prescribed Vibativ?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.